$5.930
-0.040 (-0.67%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy STLN Stock?
Starling Oncology, Inc. is not a good buy right now due to its negative fundamentals and recent performance. The current price is $6.17, and the forward P/E ratio is 0, indicating no expected earnings growth. Additionally, the stock has seen a 5-day change of -4.56%, suggesting a downward trend. The primary risk is the negative P/E ratio of -17.80, which indicates the company is currently unprofitable.
STLN stock price ended at $5.93 on Friday, after losing -0.67%
(STLN) last closed at $5.93, losing -0.67%. These facts feed the 1-day and 1-week STLN price prediction above.
Forecast Drivers
STLN (STLN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bullish
Seasonality analysis for STLN
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.